Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer-Reference-Cited by-同舟云学术

Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer

Published:2024-02 Issue:1 Volume:6 Page:99-113
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Fujisaki Tomohiro,Sueta Daisuke^ORCID,Yamamoto Eiichiro,Buckley Conor,Sacchi de Camargo Correia Guilherme,Aronson Julia,Tallón de Lara Paulino,Fujisue Koichiro,Usuku Hiroki,Matsushita Kenichi,Mehran Roxana^ORCID,Dangas George D.,Tsujita Kenichi

Publisher

Elsevier BV

Reference46 articles.

1. Epidemiology of venous thromboembolism in the Framingham Heart Study;Puurunen;Thromb Res,2016

2. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J Thromb Haemost,2007

3. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;N Engl J Med,2003

4. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period;Deitcher;Clin Appl Thromb/Hemost,2006

5. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial;Lee;JAMA,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism;European Journal of Internal Medicine;2024-09

2. Reply;JACC: CardioOncology;2024-08

3. Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial;Research and Practice in Thrombosis and Haemostasis;2024-07

4. Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2;Thrombosis and Haemostasis;2024-04-29

5. The Pursuit of “Best” Anticoagulant for Cancer-Associated Thrombosis;JACC: CardioOncology;2024-02